Structure Therapeutics Inc. (ADR)

General ticker "GPCR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.7B (TTM average)

Structure Therapeutics Inc. (ADR) follows the US Stock Market performance with the rate: 28.0%.

Estimated limits based on current volatility of 2.7%: low 42.63$, high 44.95$

Factors to consider:

  • Total employees count: 220 (+35.0%) as of 2025
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [30.98$, 82.94$]
  • 2026-12-31 to 2027-12-31 estimated range: [18.02$, 51.89$]

Financial Metrics affecting the GPCR estimates:

  • Negative: with PPE of -44.6 at the end of fiscal year the price was very high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 2.28 > -0.60
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Shareholder equity ratio, % of 95.74 > 64.29
  • Negative: -0.16 < Industry inventory ratio change (median), % of 0
  • Negative: -0.75 < Inventory ratio change, % of 0

Similar symbols

Short-term GPCR quotes

Long-term GPCR plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $102.78MM $158.23MM $287.57MM
Operating Income $-102.78MM $-158.23MM $-287.57MM
Non-Operating Income $13.39MM $36.01MM $146.88MM
R&D Expense $70.10MM $108.81MM $225.25MM
Income(Loss) $-89.38MM $-122.22MM $-140.69MM
Taxes $0.24MM $0.31MM $0.52MM
Net Income(Loss)* $-89.62MM $-122.53MM $-141.20MM
Stockholders Equity $452.97MM $864.84MM $1,516.38MM
Assets $482.02MM $903.33MM $1,583.92MM
Operating Cash Flow $-79.49MM $-116.64MM $-222.20MM
Capital expenditure $2.17MM $1.29MM $3.61MM
Investing Cash Flow $-268.34MM $-358.91MM $89.80MM
Financing Cash Flow $451.53MM $515.26MM $762.52MM
Earnings Per Share** $-2.44 $-2.33 $-2.39
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.